Clinical Trial Update: Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing long-term Innohep (tinzaparin) to Warfarin for treating venous thromboembolism in cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Innohep (tinzaparin)
• Warfarin (warfarin)

Snippet

Sponsor: LEO Pharma | Conditions: Venous Thromboembolism | Phase 3 | Status: COMPLETED